Pediatric liver transplantation: ten years of experience in a multicentric program in Chile

M Uribe1, E Buckel, M Ferrario

  • 1Programa Trasplante Hepático Clinica las Condes, Hospital Luis Calvo Mackenna, Lo Fontecilla 441, Las Condes, Santiago, Chile. muribemd@hotmail.com

Transplantation Proceedings
|November 22, 2005
PubMed

Insights

Pediatric liver transplantation in Chile, initiated in 1993, achieved 81.3% graft survival at 1 year and 72% at 5 years. This study details outcomes for 132 pediatric liver transplants, focusing on indications and complications.

Area of Science:

  • Pediatric surgery
  • Hepatology
  • Transplant immunology

Background:

  • Liver transplantation is the sole curative option for end-stage liver disease in children.
  • Chile initiated its pediatric liver transplant program in 1993, contributing to global advancements in the field.

Purpose of the Study:

  • To present the experience and outcomes of pediatric liver transplantation performed in Chile between 1993 and 2004.
  • To analyze indications, surgical techniques, complications, and survival rates in pediatric liver transplant recipients.

Main Methods:

  • Retrospective analysis of 132 pediatric orthotopic liver transplants (OLT) performed from 1993 to 2004.
  • Detailed review of patient demographics, indications (biliary atresia, acute liver failure), surgical procedures (complete, reduced, split, auxiliary, living-related grafts), vascular and biliary reconstruction techniques, immunosuppression protocols, and complication rates.
  • Actuarial graft survival analysis was performed.

Main Results:

  • The most common indications were biliary atresia (43.1%) and acute liver failure (20.4%).
  • Biliary complications (21.4%) and vascular complications (13%) were the most frequent issues. 66 patients experienced acute rejection.
  • Actuarial graft survival was 81.3% at 1 year and 72% at 5 years. For acute liver failure, survival was 75.9% at 1 year and 67.8% at 5 years.

Conclusions:

  • Pediatric liver transplantation in Chile yielded results comparable to international standards.
  • The program demonstrated successful management of indications, complications, and immunosuppression in pediatric liver transplant recipients.
  • Long-term graft survival rates support the efficacy of the established protocols.